Loading...
Tau spread, apoE, inflammation, and more: Rapidly evolving basic science in AD
To date, Alzheimer's disease (AD) drug candidates have produced negative results in human trials and progress moving new targets out of the laboratory and into trials has been slow. However, based on three decades of previous work, there is reason to hope that amyloid-based and other novel ther...
Na minha lista:
| Udgivet i: | Neurol Clin |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5417853/ https://ncbi.nlm.nih.gov/pubmed/28410655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ncl.2017.01.001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|